Sigma Healthcare
Sigma Healthcare Limited is an Australian pharmaceutical wholesale and distribution company supplying healthcare products and pharmacy retail services nationwide. The company operates large-scale distribution centers delivering prescription medicines, over-the-counter products, and retail merchandise to community pharmacies and hospital networks. Its primary revenue streams consist of wholesale pharmaceutical sales, logistics service charges, brand franchise fees, and retail marketing services provided to pharmacy member networks. Sigma Healthcare serves independent retail pharmacies, hospital dispensaries, and franchised pharmacy brands including Amcal, Discount Drug Stores, and Guardian. The company occupies a major market position as one of Australia's primary national pharmaceutical wholesalers. Sigma Healthcare Limited is headquartered in Rowville, Australia, and its ordinary shares are listed on the Australian Securities Exchange.
28 of the funds FundTelligence covers report a position in Sigma Healthcare.
- Legal name
- Sigma Healthcare Ltd.
- Sector
- Health Care
- Country
- Australia
- Funds holding it
- 28
Funds holding Sigma Healthcare
- Lannebo Marknad Pacific — Lannebo · 0.86 % (full portfolio disclosed, June 2026)
- Danske Invest Index Pacific incl. Canada ex. Japan Restricted — Danske Invest · 0.57 % (full portfolio disclosed, July 2026)
- BlackRock iShares MSCI World Health Care Sector ESG UCITS ETF — BlackRock · 0.54 % (full portfolio disclosed, October 2026)
- Captor Scilla Global Equity — Captor Fund Management · 0.31 % (full portfolio disclosed, June 2026)
- KLP AksjeAsia Indeks — KLP · 0.14 % (full portfolio disclosed, June 2026)
- Danske Invest Global Index Restricted — Danske Invest · 0.09 % (full portfolio disclosed, September 2026)
- DNB Climate Index — DNB · 0.09 % (full portfolio disclosed, September 2026)
- Handelsbanken Utviklede Markeder Index Criteria — Handelsbanken · 0.04 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 28 funds holding it.